|Bid||56.04 x 1100|
|Ask||56.30 x 800|
|Day's Range||55.92 - 57.28|
|52 Week Range||51.93 - 82.15|
|Beta (3Y Monthly)||1.21|
|PE Ratio (TTM)||N/A|
|Earnings Date||Apr 30, 2019 - May 6, 2019|
|Forward Dividend & Yield||2.00 (3.48%)|
|1y Target Est||76.76|
NEW ORLEANS, March 22, 2019 -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending.
CVS Health will be presenting three Alabama colleges with grants to advocate for, adopt and implement smoke- and tobacco- free campus policies. Lawson State Community College in Birmingham, Lurleen B. Wallace Community College and Andalusia and the University of West Alabama in Livingston will receive a total of $59,786 in grants from the CVS Health Foundation. “A critical goal in building healthier communities across the country is reducing tobacco-use, which remains one of the leading causes of preventable death in this country,” said Eileen Howard Boone, president of the CVS Health Foundation.
CVS (NYSE:CVS) announced that it will soon start selling CBD products in 800 stores and eight states.Source: Mike Mozart via FlickrCBD refers to cannabidiol, which is a hemp-based product that is part of the cannabis family, but differs from marijuana as the latter has TCH, which is the psychoactive chemical in the plant. Meanwhile, CBD is not psychoactive, meaning it does not incapacitate it users and may have medicinal benefits.CVS said Wednesday that it will start selling CBD products, including creams, sprays and roll-ons, which will serve as "an alternative source of relief." Some believe the substance helps with anxiety, pain, inflammation and cancer, although the research to back up this claims is anecdotal-the only FDA-backed CBD oil helps with seizures for severe forms of epilepsy.InvestorPlace - Stock Market News, Stock Advice & Trading Tips"We are carrying hemp-derived CBD products in select states to help meet consumer demand for alternative care options," said CVS Health Spokesperson, Mike DeAngelis. The company will partner up with a company to test the quality of the CBD products available in its drug stores.Only consumers in the states of Alabama, California, Colorado, Illinois, Indiana, Kentucky, Maryland and Tennessee will have access to these products at their local CVS locations at first. Claims surrounding how effective these CVS CBD products are will vary from item to item.CVS stock is down about 1.6% on Friday following the news. More From InvestorPlace * 5 Cloud Stocks to Help Your Portfolio Fly * 10 Stocks on the Rise Heading Into the Second Quarter * 7 Beaten-Up Stocks to Buy as They Reverse Course Compare Brokers The post CVS to Sell CBD Products in 800 Stores -- What and Where? appeared first on InvestorPlace.
NEW YORK, NY / ACCESSWIRE / March 22, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders ...
NEW YORK , March 22, 2019 /PRNewswire/ -- Amarin Corporation plc (AMRN) Lifshitz & Miller announces investigation into possible securities laws violations in connection with allegations that Amarin administered ...
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
AgraFlora Organics International (CSE: AGRA) (OTCPK: PUFXF) is teaming up with Dixie Brands (CSE: DIXI.U) (OTC: DXBRF) (Frankfurt: 0QV) to the manufacture, sale and distribution of cannabis-infused products within legalized markets in the European Union. According to a research report by Prohibition Partners, the cannabis market in the EU may represent as much as €123 […]The post Cannabis Stock News Daily Roundup March 21 appeared first on Market Exclusive.
Former Aetna Chairman and CEO Mark Bertolini says investors currently are trading "on a basis that says, 'does this drug work today? Did this trial pass today?''"
"Levi's has been doing a great job in a tough business, but at the end of the day, I hate to chase a stock that's up big, and this one's already up enormously after its first day of trading," CNBC's Jim Cramer says. "As much as I like Levi's the business ... Levi's the stock is too rich for me at these levels," the "Mad Money" host says. Apple "needs to care about more than handsets, and its investors need to do the same" to avoid a beat down next week, he says.
"Being able to reduce those unnecessary [health care] costs, you know, the value created is going to start with a 'b' as in billion. "As we think about this new company [with Aetna], we're gonna manage it at an enterprise level," he tells CNBC's Jim Cramer. CVS Health CVS CEO Larry Merlo told CNBC Thursday that the health chain is unlocking growth opportunities despite the stock's downward trend since officially merging with Aetna in November.
NEW YORK, March 21, 2019 -- Pomerantz LLP announces that a class action lawsuit has been filed against CVS Health Corporation (“CVS” or the “Company”) (NYSE: CVS) and certain.
LOS ANGELES, CA / ACCESSWIRE / March 21, 2019 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against CVS Health Corporation (''CVS'' ...
Curaleaf Holdings Inc. (CURLF) soared more than 20% on news that drug chain CVS Health Corp. (CVS) will carry Curaleaf’s line of CBD products in more than 800 stores, per Bloomberg. The news boosted Curaleaf's market value to nearly $3.8 billion as CVS shares rose more than 2%. Curaleaf and CVS are tapping into a potentially huge market.
CEDARHURST, NY / ACCESSWIRE / March 21, 2019 / The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are encouraged to contact the firm regarding possible appointment as lead plaintiff and a preliminary estimate of their recoverable losses. If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court.
It's too early to know if CBD products will fly off the shelves. But this U.S. marijuana stock is flying high after announcing its deal with the pharmacy chain.
Cannabis stocks were mostly lower Thursday, with Curaleaf Holdings Inc. a standout after announcing a partnership with drugstore chain CVS Health Corp. on a line of CBD products.
NEW YORK, March 21, 2019 -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of CVS.
HARTFORD, Conn. , March 21, 2019 /PRNewswire/ -- Aetna , a CVS Health (NYSE:CVS) business, is offering resources to members who have been affected by floods in Illinois , Iowa , Kansas , Michigan , Nebraska ...
U.S. cannabis retailer Curaleaf Holdings Inc. said late Wednesday that it has inked a deal with CVS Health Corp. to carry its line of cannabidiol, or CBD, products.
to begin selling hemp products at 800 stores in 10 states. The Massachusetts-based cannabis company announced the distribution deal during its conference call Wednesday discussing its fourth-quarter results. Hemp lotions and transdermal patches from Curaleaf will be sold in stores starting this week, company executives said, according to a report from Marijuana Business Daily.
The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are encouraged to contact the firm regarding possible appointment as lead plaintiff and a preliminary estimate of their recoverable losses. If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court.
In this week's Family First segment on YFI PM, we break down new concerns over kale, tax refunds, and the latest break-through for postpartum depression.
CVS is putting the idea behind its Aetna merger to the test with a new Health Hub concept store in Houston, with one-stop shopping for managing your chronic conditions. Customers can get in store checkups, help from a dietician, even yoga classes. As m...
In this preview of CNBC's Jim Cramer exclusive interview with CVS Health CEO Larry Merlo, the two discuss the company's decision to offer CBD products in stores in 8 states.